The first experience with sodium‐glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure
Abstract In congenitally corrected transposition of the great arteries, the morphological right ventricle supports the systemic circulation. This chronic exposure to pressure overload ultimately leads to systemic right ventricular (sRV) dysfunction and heart failure. Pharmacological options for the...
Saved in:
Main Authors: | Anastasia D. Egorova, Marieke Nederend, Laurens F. Tops, Hubert W. Vliegen, Monique R.M. Jongbloed, Philippine Kiès |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resultados a corto y largo plazo tras trasplante cardíaco en pacientes con cardiopatías congénitas
by: Marta Molina, et al.
Published: (2025-01-01) -
Paving the Way for Integrated Advanced Heart Failure and Adult Congenital Heart Disease Training
by: William H. Marshall V., MD, et al.
Published: (2025-03-01) -
Electrocardiographic Changes in Pregnant Patients With Congenital Heart Disease
by: Maria A. Pabon, et al.
Published: (2025-01-01) -
Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
by: Yang Cao, et al.
Published: (2022-06-01) -
Clinical, demographic characteristics and results of the long term follow-up in adolescents and adults with congenital heart disease
by: I.G. Lebid
Published: (2016-05-01)